The complex epilepsy patient: Intricacies of assessment and treatment

Epilepsia

Volumn 44, Issue SUPPL. 5, 2003, Pages 3-8

  Kanner, Andres M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Depression; Epilepsy; Psychiatric comorbidities

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CYTARABINE; FLUOXETINE; HOMOCYSTEINE; IMIPRAMINE; LAMOTRIGINE; METHOTREXATE; NORADRENALIN; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TENIPOSIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VIGABATRIN; VINCRISTINE; ZONISAMIDE;

ACNE; AGGRESSIVENESS; AGITATION; ANHEDONIA; ANXIETY; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONCENTRATION LOSS; CONFERENCE PAPER; DEPRESSION; DIPLOPIA; DISEASE ASSOCIATION; EPILEPSY; FATIGUE; GINGIVA DISEASE; HAIR LOSS; HEADACHE; HUMAN; IRRITABILITY; MEMORY DISORDER; MENTAL DISEASE; MOUTH DISEASE; NERVOUSNESS; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RASH; REMISSION; RESTLESSNESS; RISK FACTOR; SEIZURE THRESHOLD; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; STOMACH DISEASE; TREATMENT INDICATION; TREATMENT PLANNING; TREMOR; VERTIGO; VISUAL IMPAIRMENT; WEIGHT GAIN;

EID: 0042572219     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.44.s.5.2.x     Document Type: Conference Paper

References (33)

1. Anthony JC, Eaton WW, Henderson AS. Looking to the future in psychiatric epidemiology. Epidemiol Rev 1995;17:240-2.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
3. Rutter M, Graham P, Yule WA. Neuropsychiatric study in childhood. Philadelphia: JP Lippincott, 1970.
4. Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999;53(suppl 2):S26-32.
5. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology 2002;59(suppl 4):S48-55.
6. Blum D, Reed M, Metz A. Prevalence of major affective disorders and manic/hypomanic symptoms in persons with epilepsy: a community survey [Abstract]. Neurology 2002;58(suppl 3):A175.
7. Blumer D. Epilepsy and disorders of mood. In:Smith D, Treiman D, Trimble M, eds. Neurobehavioral problems in epilepsy. New York: Raven Press, 1991.
8. Kanner AM, Balabanov A. Depression and epilepsy. How closely are they related? Neurology 2002;58(suppl 5):S27-39.
9. Quiske A, Helmstaedter C, Lux S, Elger CE. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000;39:121-5.
10. Septien L, Giroud M, Didi-Roy R, et al. Depression and partial epilepsy: relevance of laterality of the epileptic focus. Neurol Res 1993;15:136-8.
11. Mendez MF, Engebrit B, Doss R, Grau R. The relationship of epileptic auras and psychological attributes. J Neuropsychiatry Clin Neurosci 1996;8:287-92.
12. Forsgren L, Nystrom L. An incident case-referrent study of epileptic seizures in adults. Epilepsy Res 1990;6:66-81.
13. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000;47:246-9.
14. Hesdorffer DC, Ludvigsson P, Hauser WA, et al. Depression is a risk factor for epilepsy in children [Aabstract]. Epilepsia 1998;39:222A.
15. Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy & Behav 2000:1:100-5.
16. Peck AW, Stern WC, Watkinson C. Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion, J Clin Psychiatry 1983:44:197-201.
17. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-20.
18. Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996;37:148-61.
19. Robertson MM. Depression in patients with epilepsy: an overview. Semin Neurol 1991;11:182-9.
20. Kraepelin E. Psychiatrie. Vol. 3, 8th ed. Leipzig: Johann Ambrosius Barth, 1923.
21. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(suppl 5):S9-20.
22. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
23. Perrine K, Hermann BP, Meador KJ, et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995;52:997-1003.
24. Lehrner J, Kalchmayr R, Serles W, et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999;8:88-92.
25. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
26. Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38:353-62.
27. Jobe PC, Dailey JW, Wernicke JF. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 1999;13:317-56.
28. Barchas JD, Altemus M. Biochemical hypotheses of mood and anxiety disorders. In: Siegel GJ, Agranoff BW. Albers RW et al, eds. Basic neurochemistry: molecular, cellular and medical aspects (CDROM). Philadelphia: Lippincott-Raven, 1998.
29. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965;122:509-22.
30. Dailey JW, Reith ME, Yan QS, et al. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. Neurosci Lett 1997;227:13-6.
31. Relling MV, Pui C-H, Sandlund JT, et al. Adverse effect of anti-convulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000;356:285-90.
32. Villikka K, Kivisto KT, Maenpaa MD, et al. Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther 1999;66:589-93.
33. Sillanpaa M, Jalava M, Keleva O, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338:1715-22.